PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Fibrosis D005355 23 associated lipids
Folliculitis D005499 7 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Goiter D006042 4 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Headache D006261 4 associated lipids
Hematoma D006406 5 associated lipids
Hemolysis D006461 131 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperemia D006940 25 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypotension D007022 41 associated lipids
Hypothermia D007035 19 associated lipids
Inflammation D007249 119 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Leiomyoma D007889 8 associated lipids
Leukemia D007938 74 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Melanoma D008545 69 associated lipids
Meningoencephalitis D008590 4 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Myocardial Infarction D009203 21 associated lipids
Nasal Polyps D009298 26 associated lipids
Nerve Degeneration D009410 53 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kim HY and Kim HS Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. 2007 Immunol. Cell Biol. pmid:17130903
Tanaka Y et al. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. 2007 Mol. Pharmacol. pmid:17151289
Rahman A et al. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats. 2007 Eur. J. Pharmacol. pmid:17112500
Pettipher R et al. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. 2007 Nat Rev Drug Discov pmid:17396136
Gayarre J et al. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. 2007 Ann. N. Y. Acad. Sci. pmid:17405918
Hagens WI et al. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. 2007 Pharm. Res. pmid:17245650
Sugimoto M et al. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17250998
Li X et al. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. 2007 Nephrol. Dial. Transplant. pmid:17255125
Yang C et al. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. 2007 Am. J. Pathol. pmid:17255338
Schäffler A et al. Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin". 2007 Obesity (Silver Spring) pmid:17299102
Petrova LN et al. Effect of prostaglandins E2 and D2 on presynaptic NMDA receptors in rat cerebral cortex. 2007 Bull. Exp. Biol. Med. pmid:18457019
Li CF et al. [Effect of peroxisome proliferators-activated receptor-gamma in the mechanisms of sulindac against large intestine carcinoma]. 2007 Beijing Da Xue Xue Bao pmid:17304332
Taniguchi H et al. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. 2007 J. Neurosci. pmid:17442814
Zhang XC et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. 2007 J. Pharmacol. Exp. Ther. pmid:17483291
Ponferrada A et al. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. 2007 Gastroenterology pmid:17484875
Renedo M et al. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. 2007 Biochemistry pmid:17489560
Cerbone A et al. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. 2007 Free Radic. Biol. Med. pmid:17462534
Yano M et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. 2007 Circ. Res. pmid:17463321
Hwang J et al. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction. 2007 Biochem. Biophys. Res. Commun. pmid:17418102
Rajakariar R et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18077391
Moulin D et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. 2007 Cytokine pmid:18023358
Mizutani N et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. 2007 J. Immunol. pmid:18025192
Kushikata T et al. [Sleep and anesthesia--Part 1, Recent findings in research]. 2007 Masui pmid:17877045
Kershaw EE et al. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17848638
Rollins MD et al. Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. 2006 Sep-Oct J. Gastrointest. Surg. pmid:16966031
Goya K et al. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. 2006 Sep-Oct J. Diabetes Complicat. pmid:16949522
Castellani ML et al. Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation. 2006 Oct-Dec Int. J. Biol. Markers pmid:17177158
Lappas M et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. 2006 Nov-Dec Placenta pmid:16434095
Urade Y Twenty-fifth anniversary of the discovery of somnogenic activity of prostaglandin D2: sleep research directed by Osamu Hayaishi. 2006 May-Jun IUBMB Life pmid:16754308
Okano M et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. 2006 May-Jun Am J Rhinol pmid:16871941
Guyer BJ et al. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. 2006 May-Jun Allergy Asthma Proc pmid:16913263
Kim SJ et al. Effects of methyl gallate on arachidonic acid metabolizing enzymes: Cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:17121182
Berruyer C et al. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. 2006 J. Exp. Med. pmid:17145956
Qu WM et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:17093043
Zhang A et al. Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16896186
Chaffer CL et al. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. 2006 BMC Cancer pmid:16519808
Pérez S et al. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. 2006 Biochim. Biophys. Acta pmid:16545597
Wise H Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells. 2006 Eur. J. Pharmacol. pmid:16545798
Wang XS et al. Functional characterization of human mast cells cultured from adult peripheral blood. 2006 Int. Immunopharmacol. pmid:16546715
Sawai H et al. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. 2006 Mol. Cancer Res. pmid:16547153
Fu YG et al. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. 2006 Cancer Lett. pmid:16412567
Wung BS et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells. 2006 Life Sci. pmid:16413037
Mathiesen JM et al. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. 2006 Mol. Pharmacol. pmid:16418339
Barreto EO et al. High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes. 2006 Life Sci. pmid:16647092
Funovics P et al. Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells. 2006 Prostaglandins Other Lipid Mediat. pmid:16647637
Jin MH et al. Anti-inflammatory activity of Ailanthus altissima in ovalbumin-induced lung inflammation. 2006 Biol. Pharm. Bull. pmid:16651713
Mohri I et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. 2006 J. Neurosci. pmid:16624958
Hauser B et al. Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. 2006 Intensive Care Med pmid:16534570
Lee SJ et al. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. 2006 Mol. Pharmacol. pmid:16611854
Herlong JL and Scott TR Positioning prostanoids of the D and J series in the immunopathogenic scheme. 2006 Immunol. Lett. pmid:16310861
Rockwell CE et al. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. 2006 Mol. Pharmacol. pmid:16611855
Arnold R and König W Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells. 2006 Virology pmid:16616290
Sugimoto M et al. Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16815697
Schwartz MS et al. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16716772
Na HK and Surh YJ Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. 2006 Mol. Carcinog. pmid:16673384
Brazís P et al. Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. 2006 Vet. Dermatol. pmid:16674731
Hickson-Bick DL et al. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. 2006 Shock pmid:16680021
Son MJ et al. Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:16681032
Wang WM et al. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts]. 2006 Zhonghua Yi Xue Za Zhi pmid:16681946
Sun K et al. PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression. 2006 Acta Pharmacol. Sin. pmid:16723090
Ou Z et al. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat. 2006 Brain Res. pmid:16725118
Lee S et al. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. 2006 Nephrol. Dial. Transplant. pmid:16728429
Rajasingh J and Bright JJ 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. 2006 Exp. Cell Res. pmid:16737695
Wang Z et al. Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. 2006 J. Biol. Chem. pmid:16737963
Yasugi E et al. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. 2006 Dev. Growth Differ. pmid:16573735
Cuzzocrea S Peroxisome proliferator-activated receptors and acute lung injury. 2006 Curr Opin Pharmacol pmid:16580256
Brannan JD et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. 2006 Eur. Respir. J. pmid:16707393
Ye P et al. [The role of peroxisome proliferator-activated receptor gamma in proliferation of cardiac non myocytes]. 2006 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21162229
Shiraki T et al. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting. 2006 Biochem. J. pmid:16236024
Benkirane K et al. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16155101
Zhang YF et al. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense. 2006 Am. J. Nephrol. pmid:17183189
Fernández PL [Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies]. 2006 An R Acad Nac Med (Madr) pmid:17172222
Millán O et al. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. 2006 Carcinogenesis pmid:16113051
Pereira MP et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. 2006 J. Cereb. Blood Flow Metab. pmid:16034372
Núñez NP et al. PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. 2006 Cancer Lett. pmid:15979236
Aquila S et al. Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: its potential role on the sperm physiology. 2006 J. Cell. Physiol. pmid:16972250
Gayarre J et al. Addition of electrophilic lipids to actin alters filament structure. 2006 Biochem. Biophys. Res. Commun. pmid:16979589
Zhang YJ et al. Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2). 2006 Am. J. Nephrol. pmid:16864989
Chen ZH et al. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. 2006 J. Biol. Chem. pmid:16565077
Horiguchi T et al. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. 2006 Neuroscience pmid:16567054
Siddhivarn C et al. Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line. 2006 J. Periodont. Res. pmid:16499711
Coyle AT and Kinsella BT Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. 2006 Biochem. Pharmacol. pmid:16499875
Makino N et al. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. 2006 Cell Biochem. Biophys. pmid:16456235
Figarella K et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. 2006 Cell Death Differ. pmid:16456581
Belvisi MG et al. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. 2006 Eur. J. Pharmacol. pmid:16458290
Rolin S et al. Prostanoids as pharmacological targets in COPD and asthma. 2006 Eur. J. Pharmacol. pmid:16458293
Masuda H et al. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats. 2006 Urology pmid:16461118
Lee E et al. Anti-asthmatic activity of an ethanol extract from Saururus chinensis. 2006 Biol. Pharm. Bull. pmid:16462020
Raetz CR et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. 2006 J. Lipid Res. pmid:16479018
Nakahata Y et al. The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks. 2006 BMC Mol. Biol. pmid:16483373
Damrongsri D et al. Effects of Delta12-prostaglandin J2 on bone regeneration and growth factor expression in rats. 2006 Clin Oral Implants Res pmid:16441784
Mesquita-Santos FP et al. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. 2006 J. Immunol. pmid:16424158
Martín AR et al. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. 2006 Br. J. Pharmacol. pmid:16474422
Kang HY et al. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. 2006 Arch. Dermatol. Res. pmid:16474974
Theiner G et al. The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. 2006 Immunobiology pmid:16920486
Urade Y and Mohri I [Sleep and brain function]. 2006 No To Hattatsu pmid:16986732
Kim EH and Surh YJ 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. 2006 Biochem. Pharmacol. pmid:16987499
Diaz BL et al. Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. 2006 Biochim. Biophys. Acta pmid:17064958
Qin S et al. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. 2006 Invest. Ophthalmol. Vis. Sci. pmid:17065531
Gyles SL et al. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. 2006 Immunology pmid:17067313